Related Experiment Videos
[Prognostic factors in amyotrophic lateral sclerosis]
J Martí-Fàbregas1, J Pradas, I Illa
1Servicio de Neurología, Hospital de la Santa Creu i Sant Pau., Universitat Autònoma de Barcelona.
Neurologia (Barcelona, Spain)
|May 1, 1996
Summary
Younger age at onset significantly improves survival for amyotrophic lateral sclerosis (ALS) patients. Clinical trials for ALS should match participants by age to ensure accurate survival outcome analysis.
Area of Science:
- Neurology
- Clinical Medicine
Context:
- Amyotrophic lateral sclerosis (ALS) presents highly variable patient survival rates.
- Understanding prognostic factors is crucial for patient care and clinical trial design.
Purpose:
- To analyze the influence of clinical factors such as age of onset, sex, initial symptom, and familial history on ALS patient survival.
- To identify key predictors of survival in amyotrophic lateral sclerosis.
Summary:
- A prospective study of 71 ALS patients revealed that age at onset is a decisive prognostic factor.
- Patients under 45 years old had significantly better survival (5.8 years) compared to those over 45 (2.2 years).
- Female sex was associated with worse prognosis, likely due to later age of onset in women.
Impact:
- Age at onset is inversely related to survival in amyotrophic lateral sclerosis.
- Recommends matching treatment and control groups by age in clinical trials to accurately assess survival variables.
- Highlights the need for age stratification in ALS research and therapeutic development.